U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 215092

OMLONTI (OMIDENEPAG ISOPROPYL)
0.002%
Marketing Status: Prescription
Active Ingredient: OMIDENEPAG ISOPROPYL
Proprietary Name: OMLONTI
Dosage Form; Route of Administration: SOLUTION; OPHTHALMIC
Strength: 0.002%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N215092
Product Number: 001
Approval Date: Sep 22, 2022
Applicant Holder Full Name: SANTEN INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top